Snyder Alexandra
President at Merck, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Geoffrey von Maltzahn | M | 43 |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | 6 years |
David Tanen | M | 52 |
Two River Group Holdings LLC
Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | 20 years |
Gevorg Grigoryan | M | - |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | 6 years |
Molly Gibson | F | - |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | 6 years |
Joshua Kazam | M | 47 |
Two River Group Holdings LLC
Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | 20 years |
Noel Laman | M | 84 |
Merck, Inc.
| - |
Avak Kahvejian | M | 48 |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | 6 years |
Noubar Afeyan | M | 60 |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | - |
Arie Belldegrun | M | 74 |
Two River Group Holdings LLC
Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | 20 years |
Sean Algeo | M | - |
Two River Group Holdings LLC
Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | - |
Frances Arnold | M | 67 |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | 5 years |
Stéphane Bancel | M | 51 |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | - |
Owen Witte | M | 74 |
Two River Group Holdings LLC
Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | - |
James S. Economou | M | - |
Two River Group Holdings LLC
Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | - |
Jane Mendillo | F | 65 |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | 2 years |
Gary Pisano | M | 62 |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | - |
David Chang | M | 64 |
Two River Group Holdings LLC
Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | - |
Michael Nohaile | M | 55 |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | - |
Michael Nally | M | 48 |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | 6 years |
Christopher Wilfong | M | - |
Two River Group Holdings LLC
Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | 19 years |
Grace Larry | M | - |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | 3 years |
Nicole van de Leuv | F | - |
Two River Group Holdings LLC
Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Martin Leif Peter Fransson | M | 50 |
Princeton University
| 6 years |
James McQuade | M | - |
Princeton University
| 5 years |
Refet Soykan Gürkaynak | M | - |
Princeton University
| 4 years |
Matt Little | M | - |
Princeton University
| 4 years |
Wade Donald Pfau | M | - |
Princeton University
| 4 years |
Gian Felice | M | 51 |
Princeton University
| 5 years |
Ja-Chin Lee | M | 45 |
Princeton University
| 4 years |
Louis Beryl | M | - |
Princeton University
| 4 years |
Eric Tonkyn | M | - |
Princeton University
| 4 years |
Andrew James Casino | M | - |
Princeton University
| 4 years |
Lexi Fallon | F | - |
Princeton University
| 4 years |
James Yang | M | - |
Princeton University
| 4 years |
Yeung Kit Lo | M | 45 |
Princeton University
| 4 years |
Liz Rockett | F | - |
Princeton University
| 4 years |
Thomas William Rowland | M | - |
Princeton University
| 4 years |
John Slyconish | M | - |
Princeton University
| 4 years |
Damien Bisserier | M | - |
Princeton University
| 4 years |
Gianfranco Tripicchio | M | - |
Princeton University
| 4 years |
Glenn Rockman | M | 43 |
Princeton University
| 4 years |
James Mandel | M | - |
Princeton University
| 4 years |
Joel Moxley | M | - |
Princeton University
| 4 years |
Steven Shirreffs | M | - |
Princeton University
| 4 years |
guneet banga | M | - |
Princeton University
| 4 years |
Miller Girvin | M | - |
Princeton University
| 4 years |
Juhua Zhu | M | - |
Princeton University
| 3 years |
Mark Batsiyan | M | - |
Princeton University
| 4 years |
Michael Ciklin | M | - |
Princeton University
| 4 years |
Nicole Drapkin | F | - |
Princeton University
| 4 years |
Elizabeth Addonizio | M | - |
Princeton University
| 2 years |
Lynn Loo | M | - |
Princeton University
| 5 years |
Mark Flickinger | M | - |
Princeton University
| 4 years |
David Alcaly | M | - |
Princeton University
| 4 years |
Serena Dayal | F | - |
Princeton University
| 4 years |
Sean Cameron | M | - |
Princeton University
| 4 years |
Nate Lowery | M | - |
Princeton University
| 4 years |
Lindsay Rosner | F | - |
Princeton University
| 4 years |
Allyson Alimansky | F | - |
Princeton University
| 3 years |
Allison Ball Swope | F | - |
Princeton University
| 4 years |
Ron Gonen | M | - |
Princeton University
| 1 years |
John G. Quigley | M | - |
Princeton University
| 3 years |
Ben Davenport | M | - |
Princeton University
| 9 years |
Alexander G. Liloia | M | - |
Princeton University
| 4 years |
Christopher Loose | M | 43 |
Princeton University
| 4 years |
Maggie Sahlman | F | - |
Princeton University
| 4 years |
Matthew J. Bacal | M | - |
Princeton University
| 4 years |
John Locke | M | 39 |
Princeton University
| 4 years |
Christine Hunsicker | F | - |
Princeton University
| 4 years |
Alex Nivelle | M | - |
Princeton University
| 4 years |
David Bordeau | M | - |
Princeton University
| 4 years |
Steven J. Healy | M | 62 |
Princeton University
| 6 years |
David Shyu | M | - |
Princeton University
| 4 years |
Daniel Riley | M | - |
Princeton University
| 4 years |
Ilya Koffman | M | - |
Princeton University
| 4 years |
Aleem Remtula | M | 44 |
Princeton University
| 4 years |
Gene Y. Kim | M | - |
Princeton University
| 4 years |
Pauline Reader | F | - |
Princeton University
| 4 years |
Laurence Bleicher | M | - |
Princeton University
| 3 years |
Joseph M. Juliano | M | 47 |
Princeton University
| 4 years |
Scott A. Freishtat | M | - |
Princeton University
| 4 years |
Nate L. Walton | M | 74 |
Princeton University
| 4 years |
Owen Tanzer | M | - |
Princeton University
| 4 years |
Alan Robert Boswell | M | 45 |
Princeton University
| 4 years |
Jack Studer | M | - |
Princeton University
| 4 years |
Brendan Wallace | M | 42 |
Princeton University
| 4 years |
Jared P. Mann | M | - |
Princeton University
| 4 years |
Amy Widdowson | F | - |
Princeton University
| 4 years |
Andrew Levin | M | 47 |
Princeton University
| 4 years |
Marin Soljacic | M | - |
Princeton University
| 3 years |
Eli David Scher | M | 44 |
Princeton University
| 4 years |
Wendy M. Phillips | F | - |
Princeton University
| 4 years |
Sujay Jaswa | M | 44 |
Princeton University
| 4 years |
Karen Karniol-Tambour | F | - |
Princeton University
| 4 years |
Philippe Crampe | M | - |
Princeton University
| 4 years |
Heather L. Faust | F | 44 |
Princeton University
| 4 years |
Tim Ferriss | M | - |
Princeton University
| 5 years |
Dev Chugh | M | - |
Princeton University
| 4 years |
Mark W. Phanitsiri | M | - |
Princeton University
| 4 years |
Graham Sheldon | M | - |
Princeton University
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 99 | 99.00% |
Philippines | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Snyder Alexandra
- Personal Network